These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31698697)

  • 21. Multimodal nanoparticle imaging agents: design and applications.
    Burke BP; Cawthorne C; Archibald SJ
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-Animal Molecular Imaging for Preclinical Cancer Research: .μPET and μ.SPECT.
    Cuccurullo V; Di Stasio GD; Schillirò ML; Mansi L
    Curr Radiopharm; 2016; 9(2):102-13. PubMed ID: 26503290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.
    Barazzetti G; Hurst SA; Mauron A
    Stem Cells Transl Med; 2016 Aug; 5(8):1058-66. PubMed ID: 27334488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents.
    De Souza R; Spence T; Huang H; Allen C
    J Control Release; 2015 Dec; 219():313-330. PubMed ID: 26409122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
    Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical models of shock and sepsis: what can they tell us?
    Marshall JC; Deitch E; Moldawer LL; Opal S; Redl H; van der Poll T
    Shock; 2005 Dec; 24 Suppl 1():1-6. PubMed ID: 16374365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Back to the Future for Clinical Oncology.
    Chabner BA
    Oncologist; 1996; 1(1 & 2):I. PubMed ID: 10387977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy.
    Espedal H; Fonnes T; Fasmer KE; Krakstad C; Haldorsen IS
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Cardiac Magnetic Resonance Imaging.
    Lee SE; Nguyen C; Xie Y; Deng Z; Zhou Z; Li D; Chang HJ
    Korean Circ J; 2019 Feb; 49(2):146-159. PubMed ID: 30468040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of Small Animal Imaging with PET, PET/CT, and PET/MR Imaging.
    Nanni C; Torigian DA
    PET Clin; 2008 Jul; 3(3):243-50. PubMed ID: 27156660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses.
    Petralia G; Padhani AR; Pricolo P; Zugni F; Martinetti M; Summers PE; Grazioli L; Colagrande S; Giovagnoni A; Bellomi M;
    Radiol Med; 2019 Mar; 124(3):218-233. PubMed ID: 30430385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of computational small animal models and their applications in preclinical imaging and therapy research.
    Xie T; Zaidi H
    Med Phys; 2016 Jan; 43(1):111. PubMed ID: 26745904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
    Wagenaar DJ; Kapusta M; Li J; Patt BE
    Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The translatability of animal models for clinical development: biomarkers and disease models.
    Wendler A; Wehling M
    Curr Opin Pharmacol; 2010 Oct; 10(5):601-6. PubMed ID: 20542730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging in active surveillance-a modern approach.
    Giganti F; Moore CM
    Transl Androl Urol; 2018 Feb; 7(1):116-131. PubMed ID: 29594026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-animal preclinical nuclear medicine instrumentation and methodology.
    Rowland DJ; Cherry SR
    Semin Nucl Med; 2008 May; 38(3):209-22. PubMed ID: 18396180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage.
    Leclerc JL; Garcia JM; Diller MA; Carpenter AM; Kamat PK; Hoh BL; Doré S
    Front Mol Neurosci; 2018; 11():71. PubMed ID: 29623028
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.